Theraclion SA (EPA:ALTHE)
France · Delayed Price · Currency is EUR 0.6500
+0.0100 (1.56%)
At close: Nov 28, 2025
Theraclion Market Cap
Theraclion has a market cap or net worth of €30.54 million as of November 28, 2025. Its market cap has increased by 95.14% in one year.
Market Cap
30.54M
Enterprise Value
33.95M
Revenue
1.87M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.65
Market Cap Chart
Since April 25, 2014, Theraclion's market cap has decreased from 37.53M to 30.54M, a decrease of -18.63%. That is a compound annual growth rate of -1.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 30.54M | 100.44% |
| Dec 31, 2024 | 15.24M | -11.33% |
| Dec 29, 2023 | 17.18M | -34.28% |
| Dec 30, 2022 | 26.15M | -12.29% |
| Dec 31, 2021 | 29.81M | -3.22% |
| Dec 31, 2020 | 30.80M | 24.88% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 144.39B |
| Sanofi | 104.93B |
| Sartorius Stedim Biotech | 19.75B |
| bioMérieux | 12.90B |
| Eurofins Scientific SE | 10.50B |
| Ipsen | 10.22B |
| ABIVAX Société Anonyme | 8.45B |
| Virbac | 3.09B |